Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Miravant Pharmaceuticals, Inc.”

9 pharma patents match "Miravant Pharmaceuticals, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 9
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 9 pharmaceutical patents matching "Miravant Pharmaceuticals, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

9 results for “Miravant Pharmaceuticals, Inc.” · 30,257 patents in full index Clear search

  1. US 7521551

    Chlorins possessing fused ring systems useful as photoselective compounds for photodynamic therapy

    Miravant Pharmaceuticals, Inc. · Granted Apr 21, 2009 · Expires Apr 16, 2029

    granted
  2. US 6906050

    Substituted porphyrin and azaporphyrin derivatives and their use in photodynamic therapy, radioimaging and MRI diagnosis

    Miravant Pharmaceuticals, Inc. · Granted Jun 14, 2005 · Expires Jun 9, 2025

    expired
  3. US 6827926

    Metallotetrapyrrolic photosensitizing agents for use in photodynamic therapy

    Miravant Pharmaceuticals, Inc. · Granted Dec 7, 2004 · Expires Dec 2, 2024

    expired
  4. US 6794505

    Chlorins possessing fused ring systems useful as photoselective compounds for photodynamic therapy

    Miravant Pharmaceuticals, Inc. · Granted Sep 21, 2004 · Expires Sep 16, 2024

    expired
  5. US 6605606

    Solid forms of tin ethyl etiopurpurin and processes for producing such forms

    Miravant Pharmaceuticals, Inc. · Granted Aug 12, 2003 · Expires Aug 7, 2023

    expired
  6. US 6462192

    Processes for large scale production of tetrapyrroles

    Miravant Pharmaceuticals, Inc. · Granted Oct 8, 2002 · Expires Oct 3, 2022

    expired
  7. US 6444194

    Indium photosensitizers for PDT

    Miravant Pharmaceuticals, Inc. · Granted Sep 3, 2002 · Expires Aug 29, 2022

    expired
  8. US 6376483

    Bacteriochlorins and bacteriopurpurins useful as photoselective compounds for photodynamic therapy and a process for their production

    Miravant Pharmaceuticals, Inc. · Granted Apr 23, 2002 · Expires Apr 18, 2022

    expired
  9. US 6054449

    Compounds and method for PDT of intimal hyperplasia and other diseases

    Miravant Pharmaceuticals, Inc. · Granted Apr 25, 2000 · Expires Apr 20, 2020

    expired